CYP cynata therapeutics limited

Ann: Cynata to Acquire IP from Tekcyte, page-47

  1. 4,159 Posts.
    lightbulb Created with Sketch. 1467
    "DFU trial isn't impressive will be worth nothing"

    You are so confident, NOT.

    While I am fairly sure that the trial won't prove the cells work, I am confident that the treatment is having a great impact on the quality of life of those patients with DFU.

    The worst-case is that the cells don't work but the dressing does.
    The best case would be if both work.
    But that is still to be proven.
    This gives CYP a fall back, it is no longer a one tech company, it now has 2 separate technologies, either could be a company maker. My guess is that this bandage , unseeded will be in use before your cells go commercial.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.0¢
Change
-0.005(3.03%)
Mkt cap ! $36.15M
Open High Low Value Volume
16.5¢ 16.5¢ 16.0¢ $73.23K 457.5K

Buyers (Bids)

No. Vol. Price($)
1 31250 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
16.5¢ 27550 2
View Market Depth
Last trade - 16.10pm 23/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.